ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Peter Boyle Elected IARC Director

May 23, 2003

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993

In Brief: No Intention Of Retiring, DeVita Says; Bresnick To Head Eppley; Balch Acting Director at Alabama

October 22, 1982

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013